Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EpiCrop Technologies is a private agricultural biotechnology company developing non-GMO, epigenetic crop improvement technologies to enhance yield, vigor, and resilience in plants. Founded in 2014, the company applies patent-protected epigenetic breeding methods together with genome-scale methylation analysis and predictive analytics to accelerate seed and trait development. Its business appears focused on licensing or deploying crop-performance technologies rather than developing human therapeutics. The company has described itself as using nature-based epigenetic approaches for crop improvement and has expanded research infrastructure in the St. Louis area. Although it touches biotechnology and life science broadly, it is not a healthcare, pharma, or therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EpiCrop Technologies.